NOTE: All meeting session times are in U.S. Eastern Time.

Sunday, November 6

*AABB reminds attendees that Daylight Savings Time ends on Sunday, Nov. 6 at 2:00 am.

10:00 - 11:00am ET(AM22-01-L) General Session featuring keynote speech by Simon T. Bailey
11:15am - 12:15pm ET(AM22-02-L) Under-Recognized Complications of Transfusion
(AM22-03-L) Ethical Considerations in Blood Supply Management During Critical Blood Shortages
(AM22-04-L) Oral Abstract Session- Infectious Disease
12:30 - 1:15pm ETBreak
1:30 - 2:30pm ET(AM22-05-L) Do More with Less: How to Apply the 80/20 Rule to Quality Assurance
(AM22-06-L) Convalescent Plasma: Past, Present, Future
(AM22-07-L) Oral Abstract Session- Platelets and Novel Therapeutics
2:45 - 4:15pm ET(AM22-08-L) Plenary Abstract Session
4:30 - 5:15pm ETScience & Innovation Workshop presented by Octapharma

Monday, November 7

10:00 - 11:00am ET(AM22-09-L) Managing the Apheresis Center: How Do We Produce Enough Products for the Ever-Increasing Demand?
(AM22-11-L) Oral Abstract Session- RBC Immunology - Mouse Models
11:15am - 12:15pm ET(AM22-12-L) Ask the Standards
(AM22-13-L) Effects of Transfusion on Bone Marrow Health and Transplant Outcomes in Sickle Cell Disease
(AM22-14-L) Oral Abstract Session- PBM, Hemovigilance, Education
12:30 - 1:15pm ETScience & Innovation Workshop presented by Ortho Clinical Diagnostics: Roundtable: Fact or Fiction - What to Do When Pre-Transfusion Unexpected Results Occur
1:30 - 2:30pm ET(AM22-15-L) DEIA in Focus: Advancing Equity and Inclusivity for Sexual and Gender Diverse Donors
(AM22-16-L) Lowering the Dose of Platelets – Is the Timing Right? The North American Perspective
(AM22-17-L) Oral Abstract Session- Genetic Testing and Product Quality
2:45 - 3:30pm ETScience & Innovation Workshop presented by Ortho Clinical Diagnostics: Panel: The Impact of Emerging Diseases on Blood Supply
3:45 - 4:45pm ET(AM22-18-L) Changes in the Last Decade in Patient Blood Management Practices
(AM22-19-L) Hemolysis After High-Dose Intravenous Immunoglobulin: An Under-Appreciated Sequelae
(AM22-20-L) Oral Abstract Session- Components

On-Demand Sessions

(AM22-40-O) A New Piece of Equipment... Now What?
(AM22-41-O) Armed Services Blood Program: Pioneering Collaborations to Forge Ahead Within the Military Health System Transformation
(AM22-42-O) Ask the FDA and CMS/CLIA
(AM22-43-O) Blood Safety: Epidemiological Surveillance and Risk Assessment for Emerging Pathogens
(AM22-44-O) Blood Shortage Triage Team: Engaging Hospital Leaders
(AM22-45-O) Cellular Therapy Service Quality System Considerations from a Standards Development and Application Perspective
(AM22-46-O) Clear the Way for X-Ray: Discussing Benefits of Removing and Replacing Cesium Irradiators with X-Ray
(AM22-47-O) COVID-19 – Impact on Blood Availability and Transfusion Practices in Low- and Middle-Income Countries
(AM22-48-O) Cryopreservation of Cellular Therapy Products for Allogeneic Stem Cell Transplantation During COVID-19 Pandemic and Beyond
(AM22-49-O) Cutting Edge Concepts in Pathogenesis, Diagnosis, and Treatment of Warm Autoimmune Hemolytic Anemia
(AM22-50-O) Desafíos Serológicos y Moleculares Dentro Del Sistema Del Grupo Sanguíneo Rh / Serologic and Molecular Challenges Within the Rh Blood Group System
(AM22-51-O) Global Regulatory Pathways for Biotherapies – Spotlight on New Regulations in Gulf Cooperation Council and Latin American Countries and the European Union
(AM22-52-O) Heart Transplantation and High-Risk Cardiac Surgery - Transfusion Support and Perioperative Therapies
(AM22-53-O) Impact of COVID-19 Pandemic on Blood Collection and Utilization in the United States: Preliminary Results from the 2021 National Blood Collection and Utilization Survey
(AM22-54-O) Innovations in Blood Storage to Prevent Red Blood Cell Damage
(AM22-55-O) Is It Time for the Death Knell of the Current US Apheresis Platelet Dose of 3.0 x 1011?
(AM22-56-O) Keeping up with the Donor History Task Force – Implementation of DHQ Version 3.0
(AM22-57-O) Leadership and Personal Development: Challenges for Emerging Leaders Part 1
(AM22-58-O) Leveraging Your Data Through Replication and Warehousing to Meet Your Blood Bank and Transfusion Service Needs
(AM22-59-O) Low-Yield Platelets: An Effective Solution to Our Platelet Shortage?
(AM22-60-O) LVDS - Is It Worth It?
(AM22-61-O) New Frontiers for Unmanipulated Cord Blood as Well as Its Derivatives
(AM22-62-O) Transfusion Strategies for Intracerebral Hemorrhage: Evidence, Guidelines, and Novel Approaches
(AM22-63-O) What If the Next Pandemic Is Transmissible by Transfusion? Strategies for Protecting the Blood Supply
(AM22-64-O) Who Is Transfusing Blood in Your Neighborhood? Trends in Out-of-Hospital Transfusions
(AM22-65-O) How Climate Change May Change Infectious Diseases Risks in Blood Donors and What Can Blood Operators Do to Prepare for Shifting Threat Profiles

Note: The Program may be subject to change. AABB will make any necessary updates as soon as possible.